Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 7/20 | 0.66 |
| ▸ | NOX1 | Q9Y5S8 | 9/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29637682 | 1.00 | SNCA (0.66) | SNCANOX1GAAMAPTMEN1 | |
| Bromide SCHEMBL20495634 | 0.98 | SNCA (0.64) | SNCANOX1GAAMAPTMEN1 | |
| Bromide SCHEMBL30448580 | 0.98 | SNCA (0.64) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL30065446 | 0.92 | SNCA (0.58) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL205578 | 0.92 | SNCA (0.58) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL30769565 | 0.90 | NOX1 (0.65) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL239782 | 0.90 | NOX1 (0.65) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL4708193 | 0.90 | SNCA (0.57) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL9391898 | 0.88 | SNCA (0.55) | SNCANOX1GAAMAPTMEN1 | |
| SCHEMBL19744465 | 0.85 | NOX1 (0.57) | SNCANOX1GAAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115521456-B | Polyimide for glue-free flexible copper-clad plate and preparation method thereof | 江西有泽新材料科技有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-116239546-A | Force response pure organic multiple luminescent material based on 5, 5-phenothiazine dioxide and preparation method thereof | 天津大学 | 2023-06-09 | — | — | CN | claimed |
| CN-115521456-A | Polyimide for glue-free flexible copper clad laminate and preparation method thereof | 江西有泽新材料科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-112441992-A | Nitrogen-containing heterocyclic compound and soluble porous polymer | 华南理工大学 | 2021-03-05 | — | — | CN | claimed |
| US-20180057471-A1 | Two-Electron Donating Phenothiazines and Use Thereof | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2018-03-01 | — | — | US | claimed |
| US-9590190-B2 | Terminally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-03-07 | — | — | US | claimed |
| CN-103694992-B | Hot activation delayed fluorescence material, its synthetic method and use the OLED of this hot activation delayed fluorescence material | SHENZHEN HUAXING OPTOELECTRONIC TECHNOLOGY CO., LTD. (CN) | 2016-03-16 | — | — | CN | claimed |
| CN-103204826-B | One prepares the method for 3,7-dibromo thiodiphenylamine | SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2016-02-10 | — | — | CN | claimed |
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | Shenzhen China Star Optoelectronics Technology Co. Ltd. (CN) | 2015-09-24 | — | — | US | claimed |
| CN-103694992-A | Thermal activation delay fluorescent material and synthesis method thereof as well as OLED device using thermal activation delay fluorescent material | SHENZHEN HUAXING OPTOELECT TEC | 2014-04-02 | — | — | CN | claimed |
| CN-103204826-A | Method for preparing 3, 7-dibromophenothiazin | UNIV SHAANXI SCIENCE & TECH | 2013-07-17 | — | — | CN | claimed |
| US-20260070880-A1 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250393469-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2025-12-25 | — | — | US | disclosed |
| EP-4651874-A2 | PHENOTHIAZINYL COMPOUNDS AND USES | Prosetta Biosciences, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12433150-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-09-30 | — | — | US | disclosed |
| WO-2011137447-A1 | ANTIVIRAL COMPOUNDS | PROSTETTA ANTIVIRAL INC. (US) | 2011-11-03 | — | — | WO | disclosed |
| US-20110178071-A1 | Antiviral Treatments | PROSETTA CORPORATION | 2011-07-21 | — | — | US | disclosed |
| WO-2008124550-A1 | PHENOTHIAZIN DERIVATIVES FOR ANTIVIRAL TREATMENTS | PROSETTA CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| US-5756356-A | COLORIMETRIC | TOYO INK MANUFACTURING CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
| EP-0735368-A1 | Method of indicating time or temperature-time accumulated value as color change, and materials therefor | TOYO INK MANUFACTURING CO., LTD. (JP) | 1996-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433150-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | ODC1, LEF1, L1CAM | SNCA 2281/4885NOX1 970/4885GAA 1983/4885 |
| US-20250393469-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SOD1, LIFR, LEF1 | SNCA 295/4885NOX1 11/4885GAA 2650/4885 |
| US-20260070880-A1 | DYNAMIN ACTIVATORS | DNM1, DNM1L, DNM2 | SNCA 643/4885NOX1 211/4885GAA 1109/4885 |
| US-20180057471-A1 | Two-Electron Donating Phenothiazines and Use Thereof | SLC6A12, SLCO1B3, SLCO1A2 | SNCA 1505/4885NOX1 3353/4885GAA 2947/4885 |
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | OCIAD1, OCIAD2, OGFOD1 | SNCA 1416/4885NOX1 901/4885GAA 2399/4885 |
| US-20110178071-A1 | Antiviral Treatments | HAVCR2, MAVS, EIF2AK2 | SNCA 862/4885NOX1 2537/4885GAA 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.